I now have a rich, multi-textbook, guideline-backed picture. Here is the comprehensive treatment answer:
Treatment of Varicose Veins
Overview: Treatment Goals
The aims of treatment are:
- Relieve symptoms (aching, heaviness, swelling)
- Prevent / treat complications (eczema, pigmentation, lipodermatosclerosis, ulceration, haemorrhage, thrombophlebitis)
- Cosmetic improvement
- Eliminate the source of reflux to prevent recurrence
The 2023 SVS/AVF/AVLS Clinical Practice Guidelines (Gloviczki et al., PMID: 37652254) represent the highest current evidence base and are referenced throughout below.
1. Conservative (Non-Interventional) Treatment
Compression Therapy
- Compression stockings reduce venous hypertension by increasing interstitial pressure and improving calf pump efficiency
- British classification:
- Class 1: 14-17 mmHg - mild; for telangiectasias, tired legs
- Class 2: 18-24 mmHg - moderate; symptomatic varicose veins, post-sclerotherapy
- Class 3: 25-35 mmHg - strong; severe CVI, lymphoedema, venous ulcers
Important caveats: Level 1 trial data show interventional treatment gives superior quality-of-life improvement over compression alone. Compliance rates are universally poor. There is no evidence that stockings prevent progression. Incorrect application can cause pressure necrosis or tourniquet effect. Compression should be used as an adjunct, not primary treatment, unless the patient refuses intervention. Always exclude significant arterial disease first (ABPI must be > 0.8).
Bailey and Love's Short Practice of Surgery, 28th Ed.
Other Conservative Measures
- Leg elevation above heart level for at least 30 min, 3-4x/day
- Regular walking - activates calf pump
- Weight loss - reduces intra-abdominal pressure
- Avoid prolonged standing
2. Interventional Treatment
Decision Framework
Truncal reflux (GSV/SSV)?
YES → Duplex ultrasound mapping → Endothermal ablation (first-line)
NO → Branch varicosities / telangiectasias → Sclerotherapy / Phlebectomy
The SVS/AVF/AVLS guidelines recommend endothermal ablation over open surgery for saphenous incompetence (Grade 1B), and endothermal ablation over foam sclerotherapy (Grade 1B).
A. Endothermal Ablation (First-Line for Truncal Reflux)
Both EVLA and RFA use tumescent local anaesthesia (TLA): dilute lidocaine solution injected pericatheter under ultrasound guidance. TLA compresses the vein onto the device, empties it of blood, dissects nerves away from the heat zone, and acts as a heat sink.
Endovenous Laser Ablation (EVLA)
- A fine glass fibre is inserted percutaneously into the GSV/SSV under ultrasound guidance, positioned 1-2 cm below the SFJ
- Laser energy (typically 1470 nm wavelength) is delivered as the fibre is withdrawn at a controlled pullback speed
- Three fibre tip designs: bare tip, divergent forward-firing, or radial/side-firing (thought to give more even energy distribution and less post-op bruising)
- Highest technical occlusion rates of any single technique
- Performed outpatient; patient mobilises immediately
Radiofrequency Ablation (RFA)
- A catheter with segmental electrode array (e.g. ClosureFAST) is introduced in the same manner
- Radiofrequency energy heats the vein wall to 120°C in 20-second treatment cycles, causing collagen contraction and fibrosis
- A 2024 meta-analysis (PMID: 38316290) found RFA and EVLA have similar occlusion rates but RFA has less post-procedural pain and bruising
| Feature | EVLA | RFA |
|---|
| Energy type | Laser (light) | Radiofrequency (electrical) |
| Mechanism | Photothermal destruction | Resistive heating → collagen contraction |
| Occlusion rate | ~95-98% | ~95-97% |
| Post-op pain | Moderate | Less |
| Post-op bruising | More | Less |
| Cost | Lower device cost | Higher device cost |
Bailey and Love's Short Practice of Surgery, 28th Ed.; Schwartz's Principles of Surgery, 11th Ed.
B. Sclerotherapy
A chemical sclerosant is injected into the vein, damaging the endothelium and causing inflammation → fibrosis → permanent occlusion.
Agents (FDA-approved):
- Sodium tetradecyl sulphate (STS) - most commonly used
- Polidocanol - fastest growing adoption; essentially painless; very low allergic/anaphylactic rate; minimal tissue necrosis risk
- Sodium morrhuate
- Glycerine
- Hypertonic saline (23.4%) - widely used but not FDA-approved for this indication
Liquid vs Foam Sclerotherapy:
| Liquid | Foam |
|---|
| Preparation | Undiluted agent | 1 part agent : 4 parts gas (air/CO₂); made with two-syringe/3-way stopcock technique ("Tessari method") or commercial kits |
| Mechanism | Direct endothelial contact | Microbubbles displace blood, prolonging endothelial contact; deeper penetration into wall |
| Guidance | Direct injection or blind | Ultrasound-guided foam (UGFS) for truncal veins |
| Best for | Telangiectasias, reticular veins (≤3 mm) | Larger varicosities, GSV/SSV reflux, perforators |
| Efficacy | Good for small veins | Higher efficacy for larger veins |
Using CO₂ as the mixing gas (instead of air) reduces the risk of neurological complications (visual disturbance, migraine, stroke) - important especially in patients with patent foramen ovale.
SVS/AVF Guidelines (Grade 1B): Liquid or foam sclerotherapy is recommended for telangiectasia, reticular veins, and varicose veins.
A 2025 network meta-analysis (PMID: 37649310) found cyanoacrylate glue and thermal methods showed highest short-term occlusion rates, with foam sclerotherapy as effective monotherapy for many patients.
Complications of sclerotherapy:
- Transient local discomfort (common)
- Hyperpigmentation (reduced by microthrombectomy of clotted blood in treated veins)
- Skin/fat necrosis if extravasation occurs (more common without US guidance)
- Allergic reaction / anaphylaxis
- Neurological events: visual disturbance, migraine, stroke (rare; risk higher with PFO)
Mulholland & Greenfield's Surgery, 7th Ed.
C. Mechanochemical Ablation (MOCA - ClariVein)
- A rotating catheter tip is introduced into the vein
- The spinning wire mechanically abrades the endothelium
- Liquid sclerosant is simultaneously infused via the catheter during pullback
- No tumescent anaesthesia required - less painful procedurally; good choice for needle-phobic patients
- Similar early occlusion rates to endothermal ablation, but higher medium-/long-term recanalisation rates
- Limitation: maximum catheter length limits treatment of very long segments; maximum safe sclerosant dose limits treatment of large/dilated veins
Bailey and Love's Short Practice of Surgery, 28th Ed.
D. Cyanoacrylate Glue (VenaSeal)
- A catheter is advanced into the GSV to 5 cm below the SFJ
- Cyanoacrylate (medical superglue) is injected in 0.1 mL aliquots as the catheter is withdrawn; the vein is compressed after each injection to seal the lumen
- No tumescent anaesthesia required - minimal intraprocedural pain
- Early efficacy comparable to thermal techniques
- Adverse effects: foreign body/hypersensitivity reactions to the adhesive have been reported (PMID: 37054883 - systematic review of glue reactions); long-term data still accumulating
- Highest consumable cost of any technique
Bailey and Love's Short Practice of Surgery, 28th Ed.
E. Ambulatory Phlebectomy (Stab Avulsion)
- Used for tributary varicosities (branch veins, not the truncal axial vein)
- Multiple 1-2 mm stab incisions (no sutures required) along the course of marked varicosities under tumescent local anaesthesia
- A phlebectomy hook or mosquito clamp grasps and extracts the vein segment
- Can be combined with any truncal ablation method
- Evidence shows fewer recurrences than sclerotherapy for tributaries, but risks include blisters, telangiectatic matting, scar formation, bruising
- CPT codes: 37765 (10-20 stab incisions), 37766 (>20 stab incisions)
Mulholland & Greenfield's Surgery, 7th Ed.; Pfenninger & Fowler's Procedures for Primary Care, 3rd Ed.
F. Open Surgery (Trendelenburg + Stripping)
Now largely superseded by endovenous techniques but still needed in certain situations.
Trendelenburg Operation (Saphenofemoral Ligation)
- Flush ligation and division of the GSV at the saphenofemoral junction (SFJ) through a groin incision
- All tributaries at the SFJ (5-6 tributaries: superficial circumflex iliac, superficial epigastric, superficial external pudendal, anterolateral/posteromedial thigh veins) must be ligated flush with the femoral vein to prevent neovascularisation and recurrence
Stripping
- A flexible stripper wire is passed down the GSV lumen from the groin incision to a small ankle or knee incision and the vein is stripped out (invagination stripping method minimises nerve injury)
- Stripping should be limited to the above-knee GSV - stripping below the knee significantly increases risk of saphenous nerve injury
- For SSV: sapheno-popliteal junction ligation through a popliteal fossa incision; sural nerve at risk during SSV stripping
Multiple Stab Avulsions
- Dilated tributaries are removed through stab incisions at the time of stripping
When is surgery still used?
- Very large, tortuous veins unsuitable for catheter insertion
- Failed endovenous techniques or complex recurrence
- Concomitant surgery requiring general anaesthesia anyway
- Anatomical variations precluding endovenous access
Mulholland & Greenfield's Surgery, 7th Ed.
G. Treatment of Specific Situations
| Situation | Preferred Treatment |
|---|
| GSV / SSV truncal reflux | Endothermal ablation (EVLA or RFA) - Grade 1B |
| Branch varicosities without truncal reflux | Foam sclerotherapy or phlebectomy |
| Telangiectasias / thread veins (<1 mm) | Liquid sclerotherapy or laser/IPL |
| Reticular veins (1-3 mm) | Liquid or foam sclerotherapy |
| Needle phobia; want to avoid TLA | MOCA (ClariVein) or cyanoacrylate glue |
| Superficial thrombophlebitis extending to within 1 cm of SFJ | Anticoagulation (fondaparinux) ± GSV ligation - both equally effective |
| Superficial thrombophlebitis not at SFJ | Compression + NSAIDs (e.g. indomethacin) |
| Post-thrombotic / secondary varicosities | Assess deep vein patency first; treat carefully |
| Varicose veins in pregnancy | Conservative (compression, elevation) until 3 months postpartum, then reassess |
H. CHIVA (Conservative and Hemodynamic treatment for Insufficiency in an Outpatient setting)
- Selective removal of only incompetent branches, preserving the saphenous trunk
- Requires meticulous pre-op duplex mapping and highly experienced operator
- Reported lower recurrence rates in selected series compared to stripping
- SVS/AVF Guidelines suggest this approach only for those with experience (Grade 2B/C)
3. Treatment of Complications
| Complication | Treatment |
|---|
| Haemorrhage | Immediate leg elevation + direct pressure; definitive treatment of underlying varicosity |
| Venous eczema | Topical corticosteroids; compression; treat underlying varicosities |
| Lipodermatosclerosis | High-compression hosiery; pentoxifylline may help; treat underlying reflux |
| Venous ulcer (C6) | Four-layer compression bandaging (first-line); wound care; early treatment of underlying reflux speeds healing (NICE recommends within 2 weeks if fit for intervention) |
| Superficial thrombophlebitis | NSAIDs + compression; fondaparinux 2.5 mg SC daily x 45 days if proximal/extensive |
4. Post-Treatment Compression
A 2024 meta-analysis (PMID: 38572582) examined compression after thermal ablation: routine post-procedural compression stockings reduce post-op pain and ecchymosis but do not significantly affect occlusion rates. Most centres advise compression for 1-2 weeks post-ablation.
Summary: Hierarchy of Treatments
1st line (truncal reflux): Endothermal ablation (EVLA or RFA) - outpatient, LA
2nd line (truncal): Ultrasound-guided foam sclerotherapy (UGFS)
3rd line (truncal): Open surgery (ligation + stripping) - if above not feasible
Tributaries: Phlebectomy or liquid/foam sclerotherapy
Telangiectasias: Liquid sclerotherapy or laser/IPL
No TLA wanted: MOCA or cyanoacrylate glue
Conservative only: Compression Class 2 + lifestyle
Key references:
- Bailey and Love's Short Practice of Surgery, 28th Ed.
- Schwartz's Principles of Surgery, 11th Ed.
- Mulholland & Greenfield's Surgery, 7th Ed.
- 2023 SVS/AVF/AVLS Guidelines - Gloviczki et al., J Vasc Surg Venous Lymphat Disord, 2024 (PMID: 37652254)
- RFA vs EVLA meta-analysis - Jiang et al., 2024 (PMID: 38316290)
- Sclerosant network meta-analysis - Chen et al., 2025 (PMID: 37649310)